Mar Mallo

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 9

Top Topics

End Stage Renal Disease

Prognostic Factors

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Teresa Gorria, Carme Crous, Estela Pineda Losada, Ainhoa Hernandez, Marta Domenech, Carolina Sanz, Pedro Jares, Ana María Muñoz-Mármol, Oriol Arpí-Llucía, Bárbara Melendez, Marta Gut, Anna Esteve, Anna Esteve-Codina, Genis Parra, Francesc Alameda, Cristina Carrato, Iban Aldecoa, Mar Mallo, Nuria de la Iglesia, Carmen Balana
The C250T Mutation of TERTp Might Grant a Better Prognosis to Glioblastoma by Exerting Less Biological Effect on Telomeres and Chromosomes Than the C228T Mutation. Cancers 16 (4) (2024)
Teresa Gorria, Carme Crous, Estela Pineda Losada, Ainhoa Hernandez, Marta Domenech, Carolina Sanz, Pedro Jares, Ana María Muñoz-Mármol, Oriol Arpí-Llucía, Bárbara Melendez, Marta Gut, Anna Esteve, Anna Esteve-Codina, Genis Parra, Francesc Alameda, Cristina Carrato, Iban Aldecoa, Mar Mallo, Nuria de la Iglesia, Carmen Balana
The C250T Mutation of TERTp Might Grant a Better Prognosis to Glioblastoma by Exerting Less Biological Effect on Telomeres and Chromosomes Than the C228T Mutation. Cancers 16 (4) (2024)
Mar Mallo, Heinz Tuechler, Leonor Arenillas, Sophie Raynaud, Thomas Cluzeau, Lee-Yung Shih, Chiang Tung-Liang, Christina Ganster, Katayoon Shirneshan, Detlef Haase, Martí Mascaró, Laura Palomo, José Cervera, Esperanza Such, Nicola Trim, Sally Jeffries, Emma Ridgway, Giovanni Marconi, Giovanni Martinelli, Francesc Solé
Regions of homozygosity confer a worse prognostic impact in myelodysplastic syndrome with normal karyotype. EJHaem 4 (2) (2023)
Mar Mallo, Heinz Tuechler, Leonor Arenillas, Sophie Raynaud, Thomas Cluzeau, Lee-Yung Shih, Chiang Tung-Liang, Christina Ganster, Katayoon Shirneshan, Detlef Haase, Martí Mascaró, Laura Palomo, José Cervera, Esperanza Such, Nicola Trim, Sally Jeffries, Emma Ridgway, Giovanni Marconi, Giovanni Martinelli, Francesc Solé
Regions of homozygosity confer a worse prognostic impact in myelodysplastic syndrome with normal karyotype. EJHaem 4 (2) (2023)
Clara Bueno, Susana Barrera, Alex Bataller, Valentín Ortiz-Maldonado, Natalina Elliot, Sorcha O'Byrne, Guanlin Wang, Montse Rovira, Francisco Gutierrez-Agüera, Juan L Trincado, María González-González, Mireia Morgades, Marc Sorigue, Paloma Bárcena, Samanta Romina Zanetti, Montserrat Torrebadell, Nerea Vega-García, Susana Rives, Mar Mallo, Francisco Solé, Adam J Mead, Irene Roberts, Supat Thongjuea, Bethan Psaila, Manel Juan, Julio Delgado, Alvaro Urbano-Ispizúa, Josep-María Ribera, Alberto Orfao, Anindita Roy, Pablo Menendez
CD34+CD19-CD22+ B-cell progenitors may underlie phenotypic escape in patients treated with CD19-directed therapies. Blood 140 (1) (2022)
Yassmine M N Akkari, Linda B Baughn, Adrian M Dubuc, Adam C Smith, Mar Mallo, Paola Dal Cin, Maria Diez Campelo, Marta S Gallego, Isabel Granada, Detlef T Haase, Brigitte Schlegelberger, Irma Slavutsky, Cristina Mecucci, Ross L Levine, Robert P Hasserjian, Francisco Solé, Brynn Levy, Xinjie Xu
Guiding the global evolution of cytogenetic testing for hematologic malignancies. Blood 139 (15) (2022)
Pamela Acha, Laura Palomo, Francisco Fuster-Tormo, Blanca Xicoy, Mar Mallo, Ana Manzanares, Javier Grau, Silvia Marcé, Isabel Granada, Marta Rodríguez-Luaces, Maria Diez Campelo, Lurdes Zamora, Francisco Solé
Analysis of Intratumoral Heterogeneity in Myelodysplastic Syndromes with Isolated del(5q) Using a Single Cell Approach. Cancers 13 (4) (2021)
Cristina Carrato, Francesc Alameda, Anna Esteve-Codina, Estela Pineda Losada, Oriol Arpí, Maria Martinez-García, Mar Mallo, Marta Gut, Raquel Lopez-Martos, Sonia Del Barco, Teresa Ribalta, Jaume Capellades, Josep Puig, Oscar Gallego, Carlos Mesia, Ana Maria Muñoz-Marmol, Ivan Archilla, Montserrat Arumí, Julie Marie Blanc, Beatriz Bellosillo, Silvia Menendez, Anna Esteve, Silvia Bagué, Ainhoa Hernandez, Jordi Craven-Bartle, Rafael Fuentes, Noemí Vidal, Iban Aldecoa, Nuria de la Iglesia, Carmen Balana
Glioblastoma TCGA Mesenchymal and IGS 23 Tumors are Identifiable by IHC and have an Immune-phenotype Indicating a Potential Benefit from Immunotherapy. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (24) (2020)
Anna Esteve-Codina, Francesc Alameda, Cristina Carrato, Estela Pineda Losada, Oriol Arpí, Maria Martinez-García, Mar Mallo, Marta Gut, Marc Dabad, Avelina Tortosa, Sonia Del Barco, Jaume Capellades, Josep Puig, Oscar Gallego, Teresa Pujol, Laura Oleaga, Juan Miguel Gil-Gil, Cristian de Quintana-Schmidt, Izaskun Valduvieco, Anna Martinez-Cardus, Beatriz Bellosillo, Ana Maria Muñoz-Marmol, Anna Esteve, Marta Domenech, Angels Camins, Jordi Craven-Bartle, Salvador Villa, Jordi Marruecos, Nuria de la Iglesia, Carmen Balana
RNA sequencing and Immunohistochemistry Reveal ZFN7 as a Stronger Marker of Survival than Molecular Subtypes in G-CIMP-negative Glioblastoma. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (2) (2020)